ClinicalTrials.gg
CompletedNCT05656703Updated Dec 19, 2022

Anesthesia Depth Increases Delirium Incidence

An interventional study of BIS guidance of anesthesia and Standard of Care in Delirium and Anesthesia Awareness, sponsored by Heidelberg University. Completed at 1 site in Germany. Open to participants aged 70 Years to 110 Years. Per ClinicalTrials.gov, last updated 2022-12-19.

Sponsored by Heidelberg University · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Registered 6 years 8 months after the study started (first participant enrolled Sep 2015, registered May 2022).
Phase
Not applicable
Study type
Interventional
Enrollment
130
Allocation
Randomized
Ages
70 Years to 110 Years
Sex
All
01

Study summary

This study aimed to determine whether targeting bispectral index (BIS) readings of 55 (light anaesthesia) was associated with a lower incidence of delirium, dementia (POD), POCD and mortality but higher rates of awareness and complications than a standard of care anaesthesia blinded to depth monitoring.

Read the detailed description

Design: Randomised-controlled, double blind study, monocentric Setting: Level 2 medical center, major surgery (non cardiac) Ethics: Ethical approval for this study (Ethikkommission II der Ruprecht-Karls-Universität Heidelberg 2013-627N-MA) was provided by the Ethical Committee II University Medicine Mannheim, University of Heidelberg, Germany (Chairperson Prof W. Striebel) on Mai 12th 2008.

Patients: n=130, aged > 70y Intervention: Light anesthesia (BIS 55 +/-5) vs. Standard of Care (BIS- blinded) Main outcome measures: Incidence of awareness, delirium, postoperative cognitive deficit (POCD), dementia (POD), memory (MAT with a computerized score for verbal working\&short term, figural working\&short term memories and well as attention level) Second aims: mortality, complications

02

Conditions studied

  • Delirium
  • Anesthesia Awareness

Keywords

  • bispectral index monitoring
  • anesthesia depth
03

In context

Delirium

1,071 studies on the registry are indexed under Delirium; 239 are open to participants now.

This study's enrollment of 130 is close to the median of 119 across 608 interventional studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Heidelberg University is the lead sponsor of 287 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years to 110 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • scheduled for major surgery above 60 min duration
  • informed consent

Exclusion criteria

Exclusion Criteria:

  • emergency surgery with large blood loss and/or preoperative cardiovascular instability, scheduled regional or neuraxial anesthesia, language barriers with the unability to understand a German audio tape, unability or unwillingness to consent,hearing disabilities
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
130 participants (actual)

Study arms

  • Experimental
    Bis Guided light anesthesia

    Patients are monitored by bispectral index and held under light anesthesia (BIS level 45 to 60)

    Device: BIS guidance of anesthesia

  • Placebo comparator
    Standard of Care

    Patients receive standard of care anesthesia, BIS monitor was covered with a blind

    Other: Standard of Care

Interventions

  • DeviceBIS guidance of anesthesia

    Anesthesia is to be directed to a specific (light) level by the dosage of administered hypnotics and analgesics

  • OtherStandard of Care

    Anesthesia is administered as usual

06

What researchers measure

Primary outcomes

  1. postoperative delirium by NUDESC

    in the hospital with NUDESC Score

    Time frame: 6 to 24 months

  2. postoperative dementia and cognitive deficit By MMSE and MAT Test

    in the hospital by MMSE and MAT (automated computerized test), after discharge by a standardized questionnaire

    Time frame: 6 to 24 months

  3. awareness, memory function

    implicit and explicit memory for intraoperative wakefulness and memory functions in general as changing conditions due to anesthesia

    Time frame: 1 to 3 days postoperative

Secondary outcomes

  1. mortality and morbidity

    death rate (in hospital and longterm mortality (death/month)) and complication rate (in hospital and longterm morbidity (complications/month))

    Time frame: 6 to 24 months

07

Study locations

1 site
  • Clinic of Anesthesiology and Critical Care Medicine, Faculty of Clinical Medicine MAnnheim, University of Heidelberg, Germany
    Mannheim, Baden-Wurttemberg 68167, Germany
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2015 to primary completion in Jun 2018, 33 months.

Of 248 non-industry interventional studies with no phase under Delirium, half reached primary completion within 27 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's 33 months is above that.

Counting every sponsor, half of 250 studies reached it within 27 months; a quarter within 12 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
May 12, 2022
First posted
Dec 19, 2022
StartActual
Sep 1, 2015
Primary completionActual
Jun 1, 2018
CompletionActual
Mar 15, 2021
Last update
Dec 19, 2022
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 19, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05656703
Responsible party
Thomas Frietsch (Associate Professor, Heidelberg University) — Principal investigator
First posted
Dec 19, 2022
Start date
Sep 1, 2015
Primary completion
Jun 1, 2018
Completion
Mar 15, 2021
Last update
Dec 19, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion